Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?

Clinical Endocrinology

Volumn 68, Issue 3, 2008, Pages 338-342

  Rosario, P W ^a,b   Purisch, S ^a  

^a Endocrinology Service   (Brazil)

^b Centro de Estudos e Pesquisa da Clinica de Endocrinologia e Metabologia CEPCEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROXINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; SAMPLING; THYROID CANCER; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; CLINICAL LABORATORY TECHNIQUES; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; THYROXINE; YOUNG ADULT;

EID: 39149121877     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03043.x     Document Type: Article

References (22)

1. Torlontano, M., Attard, M., Crocetti, U., Tumino, S., Bruno, R., Costante, G., D'Azzo, G., Meringolo, D., Ferretti, E., Sacco, R., Arturi, F. Filetti, S. (2004) Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. Journal of Clinical Endocrinology and Metabolism, 89, 3402 3407.
2. Pacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L. Pinchera, A. (2003) Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 3668 3673.
3. Rosario, P.W., Borges, M.A., Fagundes, T.A., Franco, A.C. Purisch, S. (2005) Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound? Clinical Endocrinology, 62, 121 125.
4. Pacini, F., Capezzone, M., Elisei, R., Ceccarelli, C., Taddei, D. Pinchera, A. (2002) Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. Journal of Clinical Endocrinology and Metabolism, 87, 1499 1501.
5. Cailleux, A.F., Baudin, E., Travagli, J.P., Ricard, M. Schlumberger, M. (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid carcinoma? Journal of Clinical Endocrinology and Metabolism, 85, 175 178.
6. Rosario, P.W., Fagundes, T.A., Rezende, L.L., Padrao, E.L., Borges, M.A. Barroso, A.L. (2006) Assessing hypothyroidism in the preparation of patients with thyroid cancer: cardiovascular risk, renal function, drug metabolism, persistence of elevated thyroid-stimulating hormone, and absence from work. Endocrinologist, 16, 25 29.
7. Rosario, P.W., Fagundes, T.A., Purisch, S., Padrao, E.L., Rezende, L.L. Barroso, A.L. (2005) Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma. Brazilian Archives of Endocrinology and Metabolism, 49, 350 358.
8. Giovanella, L., Ceriani, L., Ghelfo, A., Keller, F., Sacchi, A., Maffioli, M. Spriano, G. (2006) Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures. Clinical Chemistry and Laboratory Medicine, 44, 648 652.
9. Smallridge, R.C., Meek, S.E., Morgan, M.A., Gates, G.S., Fox, T.P., Grebe, S. Fatourechi, V. (2007) Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. Journal of Clinical Endocrinology and Metabolism, 92, 82 87.
10. Schlumberger, M., Hitzel, A., Toubert, M.E., Corone, C., Troalen, F., Schlageter, M.H., Claustrat, F., Koscielny, S., Taieb, D., Toubeau, M., Bonichon, F., Borson-Chazot, F., Leenhardt, L., Schvartz, C., Dejax, C., Brenot-Rossi, I., Torlontano, M., Tenenbaum, F., Bardet, S., Bussiere, F., Girard, J.J., Morel, O., Schneegans, O., Schlienger, J.L., Prost, A., So, D., Archambaud, F., Ricard, M. Benhamou, E. (2007) Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. Journal of Clinical Endocrinology and Metabolism, 92, 2487 2495.
11. Iervasi, A., Iervasi, G., Ferdeghini, M., Solimeo, C., Bottoni, A., Rossi, L., Colato, C. Zucchelli, G.C. (2007) Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clinical Endocrinology, 67, 434 441.
12. Spencer, C.A., Takeuchi, M. Kazarosyan, M. (1996) Current status and performance goals for serum thyroglobulin assays. Clinical Chemistry, 42, 164 173.
13. Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J.W. Wiersinga, W. (2006) European consensus for the management of patients with thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 154, 787 803.
14. Wittekind, C., Compton, C.C., Greene, F.L. Sobin, L.H. (2002) TNM residual tumor classification revisited. Cancer, 94, 2511 2516.
15. Rosario, P.W., Maia, F.F., Fagundes, T.A., Vasconcelos, F.P., Cardoso, L.D. Purisch, S. (2004) Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. Brazilian Archives of Endocrinology and Metabolism, 48, 487 492.
16. Iervasi, A., Iervasi, G., Bottoni, A., Boni, G., Annicchiarico, C., Di Cecco, P. Zucchelli, G.C. (2004) Diagnostic performance of a new highly sensitive thyroglobulin immunoassay. Journal of Endocrinology, 182, 287 294.
17. Rosario, P.W., Faria, S., Bicalho, L., Gatti Alves, M.F., Borges, M.A., Purisch, S., Padrao, E.L., Rezende, L.L. Barroso, A. (2005) Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. Journal of Ultrasound in Medicine, 24, 1385 1389.
18. Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Mazzaferri, E.L., McIver, B., Sherman, S.I. Tuttle, R.M. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 16, 109 142.
19. Maia, A.L., Ward, L.S., Carvalho, G.A., Graf, H., Maciel, R.M., Maciel, L.M., Rosario, P.W. Vaisman, M. (2007) Thyroid nodules and differentiated thyroid cancer: Brazilian Consensus. Brazilian Archives of Endocrinology and Metabolism, in press.
20. Spencer, C.A., Bergoglio, L.M., Kazarosyan, M., Fatemi, S. LoPresti, J.S. (2005) Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism, 90, 5566 5575.
21. Frasoldati, A., Pesenti, M., Gallo, M., Caroggio, A., Salvo, D. Valcavi, R. (2003) Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 97, 90 96.
22. Rosario, P.W., Fagundes, T.A., Maia, F.F., Franco, A., Figueiredo, M.B. Purisch, S. (2004) Ultrasonography in the diagnosis of cervical recurrence in patients with differentiated thyroid carcinoma. Journal of Ultrasound in Medicine, 23, 915 920.